About this episode
In this continuation of our myeloma series, we discuss the progression of MGUS & smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment. Content: -What is the natural progression from MGUS to smoldering myeloma to multiple myeloma? - How do we risk stratify patients with a new myeloma diagnosis? - What is the role of FISH/karyotype in risk stratification in myeloma? -How do we gauge disease response in myeloma? - How do we define disease progression? - How do we define treatment response? - What is the role of minimal residual disease (MRD) in myeloma? Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast